BMS 536924,
BMS-536924,
BMS536924,
BMS-536924,
468740-43-4,
BMS 536924,
BMS536924,
UNII-40E3AZG1MX,
4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone,
40E3AZG1MX,
CHEMBL401930,
CS-0117,
HY-10262,
MLS006011171,
SCHEMBL4132577,
SCHEMBL15974144,
BDBM27879,
CHEBI:91454,
BCP02116,
ZINC6718468,
2278AH,
ABP000159,
s1012,
AKOS024458339,
AKOS025149514,
ZINC140935730,
KIN0000061,
RL03740,
SB19378,
NCGC00346460-02,
NCGC00346460-05,
SMR004702940,
BMS-536924/BMS536924,
A2238,
SW218124-2,
X5078,
S-7752,
BMS-536924, >=98% (HPLC),
J-514217,
BRD-K34581968-001-01-2,
(S)-4-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one,
4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1H-benzimidazol-2-yl)-1H-pyridin-2-one,
4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydropyridin-2-one,
4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[4-methyl-6-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1H-pyridin-2-one,
4-{[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}-3-[7-methyl-5-(morpholin-4-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydropyridin-2-one,
D0M4SY,
C25H26ClN5O3,
cc-534,
UGQMURPIMYALPH-KKPVDXMRSA-N,
TP-808,
ACN-039827,
ACN-039828,
CID10390396,
CID11353973,
CID 11353973,
A11054,
Insulin-like Growth Factor-1 Receptor Inhibitor,
C504983,
129830-38-2,